Global Clinical Nutrition Market Overview 2023-2028
The global clinical nutrition market size reached US$ 47.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 78.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.35% during 2023-2028.
Clinical nutrition emphasizes the provision of vital nutrients to help individuals maintain good health and complement medical treatments. This field entails a thorough assessment of patients’ nutritional requirements, often considering their medical conditions. The objective is to ensure patients receive a precise blend of nutrients, vitamins, and minerals aligned with their unique health objectives and medical necessities. By catering to particular dietary needs, clinical nutrition contributes to the enhancement of overall well-being, aiding in prompt recovery, chronic illness management, and improved quality of life. Consequently, there is a growing global demand for clinical nutrition due to its positive impact on health outcomes.
Global Clinical Nutrition Market Trends and Drivers:
Currently, the escalation in chronic ailment cases worldwide stands as a significant driver for market expansion. Moreover, heightened awareness regarding disease control and prevention among the populace is fostering market growth. Furthermore, the market is experiencing a boost due to a surge in demand for specialized clinical products tailored to address specific medical conditions like diabetes, cardiovascular diseases, and malnutrition. Additionally, the market is being positively impacted by the increasing preference for clinical products devoid of artificial additives and allergens. The market is also benefiting from a growing emphasis on personalized dietary strategies based on individuals’ genetic and metabolic profiles.
Global Clinical Nutrition Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc and Reckitt Benckiser Group PLC
The report segmented the market on the basis of region, product, route of administration, application and end user.
Breakup by Product:
- Infant Nutrition
- Parental Nutrition
- Enteral Nutrition
Breakup by Route of Administration:
Breakup by Application:
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
Breakup by End User:
Breakup by Region:
- North America
- United States
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800